Company data
Fennec Pharmaceuticals Inc. employees and revenue per employee
FENC · Biotechnology · $372M market cap
Fennec Pharmaceuticals Inc. had 35 employees at the end of fiscal Dec 2025, up 9.4% from a year earlier. Revenue for the year was $44.6M, down 6.1% from a year earlier, or $1.28M per employee. Revenue fell while headcount grew.
Employees
35
+9.4% YoY
Revenue
$44.6M
-6.1% YoY
Revenue / employee
$1.28M
Peer median $459K
Rank in industry
27 of 108
Biotechnology
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Hover a year for the numbers.
| Year ending | Employees | Revenue | Per employee | Staff YoY | Revenue YoY |
|---|---|---|---|---|---|
| Dec 2025 | 35 | $44.6M | $1.28M | +9.4% | -6.1% |
| Dec 2024 | 32 | $47.5M | $1.49M | +10.3% | +123.7% |
| Dec 2023 | 29 | $21.3M | $733K | -19.4% | +1284.5% |
| Dec 2022 | 36 | $1.5M | $43K | — | — |
| Dec 2020 | 9 | $170,000 | $19K | — | — |
Open roles: we have not matched a verified job board for this company yet.
Fennec Pharmaceuticals Inc. against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| FENC Fennec Pharmaceuticals Inc. | 35 | $44.6M | $1.28M | Hiring into decline |
| NKTR Nektar Therapeutics | 63 | $55.2M | $877K | Hiring into decline |
| TNGX Tango Therapeutics, Inc. | 137 | $62.4M | $455K | Leaner |
| OBIO Orchestra BioMed Holdings, Inc. | 86 | $33.5M | $389K | Efficient growth |
| SEPN Septerna Inc | 130 | $46.0M | $353K | Efficient growth |
| PTGX Protagonist Therapeutics, Inc. | 132 | $46.0M | $349K | Hiring into decline |
| KYMR Kymera Therapeutics, Inc. | 238 | $39.2M | $165K | Hiring into decline |
| OCUL Ocular Therapeutix, Inc. | 325 | $51.8M | $159K | Hiring into decline |
| AGIO Agios Pharmaceuticals, Inc. | 539 | $54.0M | $100K | Efficient growth |
Questions about Fennec Pharmaceuticals Inc.
- How many employees does Fennec Pharmaceuticals Inc. have?
- Fennec Pharmaceuticals Inc. reported 35 employees for the fiscal year ending Dec 2025, in the annual report it filed on March 27, 2026. That is up 9.4% from a year earlier.
- What is Fennec Pharmaceuticals Inc.'s revenue per employee?
- Fennec Pharmaceuticals Inc. brought in $44.6M of revenue in fiscal Dec 2025, which is $1.28M per employee. That ranks 27 of 108 companies we track in Biotechnology, where the median is $459K.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare FENC with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in Fennec Pharmaceuticals Inc.'s annual reports (Form 10-K), latest filed March 27, 2026. This is data, not a recommendation to buy or sell FENC.